A. O. Mueck

2.1k total citations
80 papers, 1.5k citations indexed

About

A. O. Mueck is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, A. O. Mueck has authored 80 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Genetics, 33 papers in Endocrinology, Diabetes and Metabolism and 23 papers in Pathology and Forensic Medicine. Recurrent topics in A. O. Mueck's work include Estrogen and related hormone effects (60 papers), Menopause: Health Impacts and Treatments (30 papers) and Phytoestrogen effects and research (23 papers). A. O. Mueck is often cited by papers focused on Estrogen and related hormone effects (60 papers), Menopause: Health Impacts and Treatments (30 papers) and Phytoestrogen effects and research (23 papers). A. O. Mueck collaborates with scholars based in Germany, China and Australia. A. O. Mueck's co-authors include Harald Seeger, Xiangyan Ruan, D. Wallwiener, Santiago Palacios, Rossella E. Nappi, David Portman, Tanja Fehm, Hans Neubauer, T. H. Lippert and Jens Huober and has published in prestigious journals such as PLoS ONE, Life Sciences and The Journal of Steroid Biochemistry and Molecular Biology.

In The Last Decade

A. O. Mueck

76 papers receiving 1.5k citations

Peers

Countries citing papers authored by A. O. Mueck

Since Specialization

Citations

This map shows the geographic impact of A. O. Mueck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. O. Mueck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. O. Mueck more than expected).

Fields of papers citing papers by A. O. Mueck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. O. Mueck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. O. Mueck. The network helps show where A. O. Mueck may publish in the future.

Co-authorship network of co-authors of A. O. Mueck

This figure shows the co-authorship network connecting the top 25 collaborators of A. O. Mueck. A scholar is included among the top collaborators of A. O. Mueck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. O. Mueck. A. O. Mueck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The WHO claims estrogens are ‘carcinogenic’: is this true? 2023 ·Climacteric ·Xiangyan Ruan, A. O. Mueck	4
2	PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis 2023 ·Climacteric ·(unknown), Xiangyan Ruan, (unknown), (unknown), (unknown), A. O. Mueck	13
3	E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation 2022 ·Climacteric ·Limei Zhang, Xiangyan Ruan, (unknown), A. O. Mueck	9
4	Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view 2022 ·Climacteric ·Xiangyan Ruan, A. O. Mueck	7
5	Genitourinary syndrome of menopause in Chinese perimenopausal and postmenopausal women 2021 ·Climacteric ·Xiangyan Ruan, Luo Zhang, Yuanshan Cui, (unknown), A. O. Mueck	7
6	Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects 2017 ·The European Journal of Contraception & Reproductive Health Care ·Xiangyan Ruan, Ali Kubba, (unknown), A. O. Mueck	27
7	Risks and benefits of hormone therapy: has medical dogma now been overturned? 2014 ·Climacteric ·S. Shapiro, T. J. de Villiers, Amos Pines, David Sturdee, Rod Baber, Nick Panay, John C. Stevenson, A. O. Mueck, Henry Burger	13
8	Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial 2014 ·Maturitas ·David Portman, Santiago Palacios, Rossella E. Nappi, A. O. Mueck	108
9	Possible role of PGRMC1 in breast cancer development 2013 ·Climacteric ·Hans Neubauer, Qi Ma, Jiaolin Zhou, Qi Yu, Xiangyan Ruan, Harald Seeger, Tanja Fehm, A. O. Mueck	44
10	Attitude of German women towards hormone therapy: results of a lay survey 2013 ·Gynecological Endocrinology ·Kai J. Bühling, (unknown), (unknown), Christine Eulenburg, A. O. Mueck	2
11	Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells 2012 ·Climacteric ·Xiangyan Ruan, Hans Neubauer, Yunmei Yang, H Schneck, (unknown), Tanja Fehm, Michael A. Cahill, Harald Seeger, A. O. Mueck	48
12	Estradiol Metabolites and their Possible Role in Gynaecological Cancer 2010 ·Harald Seeger, A. O. Mueck	1
13	Comparison of the Proliferative Effects of Ethinylestradiol on Human Breast Cancer Cells in an Intermittent and a Continuous Dosing Regime 2008 ·Hormone and Metabolic Research ·Gabriele S. Merki‐Feld, Harald Seeger, A. O. Mueck	3
14	Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cells 2005 ·Life Sciences ·Harald Seeger, D. Wallwiener, A. O. Mueck	23
15	Endogenous estradiol metabolism during treatment with oral contraceptives 2004 ·International Journal of Clinical Pharmacology and Therapeutics ·A. O. Mueck, Harald Seeger, D. Wallwiener	3
16	Effects of tibolone on human breast cancer cells and human vascular coronary cells 2003 ·Archives of Gynecology and Obstetrics ·A. O. Mueck, (unknown), Harald Seeger, D. Wallwiener	12
17	Angiogenetic and Anti-Angiogenetic Effects of Estradiol and its Metabolites 2001 ·Journal of clinical and basic cardiology ·A. O. Mueck, Harald Seeger, (unknown), D. Wallwiener	5
18	The Effects of Postmenopausal Hormone Replacement Therapy and Oral Contraceptives on the Endogenous Estradiol Metabolism 2001 ·Hormone and Metabolic Research ·A. O. Mueck, Harald Seeger, T Gräser, M. Öettel, (unknown)	12
19	Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate–estradiol treatment on the proliferation of MCF-7 cells^* 2000 ·Climacteric ·(unknown), Harald Seeger, D. Wallwiener, A. O. Mueck	5
20	The effect of estradiol on urodilatin production in postmenopausal women 1998 ·Archives of Gynecology and Obstetrics ·Harald Seeger, Franz Paul Armbruster, A. O. Mueck, T. H. Lippert	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact